Skip to content

Clinical trials

Phase 2/3 trials in Peru

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Country / region: Peru Clear all

30 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20082
20092
20102
20121
20141
20152
20161
20172
20206
20212
20224
20231
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated7
Recruiting5
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC3
Hoffmann-La Roche2
Universidad Peruana Cayetano Heredia2
AstraZeneca1
Avexa1
Biogen1
Complejo Hospitalario Dr. Arnulfo Arias Madrid1
CureVac1
Daiichi Sankyo1
HilleVax1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-195
Diabetes Mellitus, Type 23
Carcinoma, Non-Small-Cell Lung2
HIV Infections2
Neurocysticercosis2
Amyotrophic Lateral Sclerosis1
Coronavirus Infections1
Demyelinating Diseases1
Dermatomyositis1
Epilepsy1

Trials

Showing 51 to 30 of 30. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.